NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Medannex Ltd

Medannex Ltd

Private
EdinburghHealthcare & Life Scienceshttps://medannex.org/

Last Round

Grant

May 11, 2026

Total Funding Raised

$14.86M

Company Overview

Medannex Ltd is a biotechnology company that develops novel monoclonal antibody therapeutics to treat cancers and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibodybiopharmaceuticaloncologyautoimmune diseaseannexin-A1drug discoverybiotechclinical trialsamesotatugtherapeutic developmentantibody drug conjugateADCprecision medicinedrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medannex Ltd Comparables

Compare Medannex Ltd with similar companies based on industry and business-model similarity.

Medannex Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Netris Pharma
81%
Alligator Bioscience
69%
Phanes Therapeutics
69%

Medannex Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 11, 2026
GrantJul 25, 2024
Series BMar 5, 2020
GrantJan 1, 2019
GrantJun 12, 2018
Seed
Aug 28, 2013

Key People

Founding team and executive leadership

Ian Abercrombie

Chief Executive Officer

Executive Team

Medannex Ltd Investors

Notable investors and investment history

Medannex Ltd investors
InvestorRounds
Morningside VenturesSeries B
Innovate UKGrant
Scottish Investment Bank (Scottish Enterprise)Series B, Grant, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 35% MoM.

  • Jun 12, 2018

    $570K grant received from Scottish Investment Bank.

Medannex Ltd Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medannex Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medannex Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range12
Year Founded2009
Last FundingMay 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.